Manchester Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93K Hold
119
﹤0.01% 981
2026
Q1
$2.85K Hold
119
﹤0.01% 965
2025
Q4
$2.69K Buy
+119
New +$2.59K ﹤0.01% 971
2022
Q3
Sell
-3,022
Closed -$59K 914
2022
Q2
$59K Hold
3,022
0.01% 354
2022
Q1
$79K Hold
3,022
0.01% 365
2021
Q4
$86K Sell
3,022
-2,908
-49% -$90.4K 0.01% 358
2021
Q3
$189K Buy
5,930
+3,101
+110% +$104K 0.03% 286
2021
Q2
$98K Buy
2,829
+229
+9% +$7.55K 0.01% 332
2021
Q1
$77K Hold
2,600
0.01% 344
2020
Q4
$80K Hold
2,600
0.01% 333
2020
Q3
$73K Hold
2,600
0.01% 310
2020
Q2
$56K Hold
2,600
0.01% 355
2020
Q1
$58K Buy
+2,600
New +$71.2K 0.01% 340

Other funds holding ELAN

Manchester Capital Management's ELAN Position: Q2 2026 in Review

Manchester Capital Management held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 119 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Manchester Capital Management first reported a position in ELAN in Q1 2020 and has held it in 13 quarters since. The position peaked at $189K in Q3 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Manchester Capital Management held 119 shares of Elanco Animal Health worth $2.93K as of Q2 2026.
  • Manchester Capital Management left its Elanco Animal Health share count unchanged in Q2 2026.
  • Elanco Animal Health made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #981 holding.
  • Manchester Capital Management first reported a position in Elanco Animal Health in Q1 2020 and has held it in 13 quarters since.
  • Manchester Capital Management's Elanco Animal Health position peaked at $189K in Q3 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.